Literature DB >> 14623872

Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH.

Andres Alonso1, Nunzio Bottini, Shane Bruckner, Souad Rahmouni, Scott Williams, Stephen P Schoenberger, Tomas Mustelin.   

Abstract

A key virulence factor for Yersinia pestis, the etiologic agent of plague, is the tyrosine phosphatase YopH, which the bacterium injects into host cells. We report that treatment of human T lymphocytes with a recombinant membrane-permeable YopH resulted in severe reduction in intracellular tyrosine phosphorylation and inhibition of T cell activation. The primary signal transducer for the T cell antigen receptor, the Lck tyrosine kinase, was specifically precipitated by a substrate-trapping YopH mutant, and Lck was dephosphorylated at its positive regulatory site, Tyr-394, in cells containing active YopH. By turning off Lck, YopH blocks T cell antigen receptor signaling at its very first step, effectively preventing the development of a protective immune response against this lethal bacterium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623872     DOI: 10.1074/jbc.M308978200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH.

Authors:  Marilisa Leone; Elisa Barile; Jesus Vazquez; Angel Mei; Donald Guiney; Russel Dahl; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-04-28       Impact factor: 2.817

2.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

3.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

4.  Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15.

Authors:  Renu Garg; Ignacio J Juncadella; Nandhini Ramamoorthi; Shobana K Ananthanarayanan; Venetta Thomas; Mercedes Rincón; Joanna K Krueger; Erol Fikrig; Christopher M Yengo; Juan Anguita
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 5.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

6.  Cytotoxic necrotizing factor-Y boosts Yersinia effector translocation by activating Rac protein.

Authors:  Manuel Wolters; Erin C Boyle; Kerstin Lardong; Konrad Trülzsch; Anika Steffen; Klemens Rottner; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

7.  Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase.

Authors:  Megan Hogan; Medhanit Bahta; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Terrence R Burke; David S Waugh; Robert G Ulrich
Journal:  Chem Biol Drug Des       Date:  2013-03       Impact factor: 2.817

8.  Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin.

Authors:  Zhiyong Ye; Cheryl Mei Ling Lee; Guang Wen Sun; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.

Authors:  Y Jeffrey Chiang; Martha S Jordan; Reiko Horai; Pamela L Schwartzberg; Gary A Koretzky; Richard J Hodes
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

10.  Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections.

Authors:  Janie Parrino; Richard S Hotchkiss; Mike Bray
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.